CAS 156223-05-1 Nootropic Powder 3-(2,4-dimethoxybenzylidene)anabaseine
Place of Origin | China |
---|---|
Brand Name | XRD |
Certification | GMP |
Model Number | 156223-05-1 |
Minimum Order Quantity | negotiable |
Price | Inquiry for Negotiable |
Packaging Details | 1-2 kg / aluminum foil bag, 25kg/ drum, as required |
Delivery Time | 1-2days after payment received |
Payment Terms | T/T bank, Western Union, Bitcoin, Etc |
Supply Ability | 100KG/ Month |

Contact me for free samples and coupons.
Whatsapp:0086 18588475571
Wechat: 0086 18588475571
Skype: sales10@aixton.com
If you have any concern, we provide 24-hour online help.
xCAS | 156223-05-1 | Product Name | GTS-21 |
---|---|---|---|
Type | Pharmaceutical Raw Materials | Appearance | White Powder |
Usage | For Nootropics | Alias | GTS 21 2HCl(DMXBA) |
Assay | 99% | Key Words | GTS 21 |
High Light | brain nootropics,memory enhancing supplements |
99% 3-(2,4-dimethoxybenzylidene)anabaseine Manufacturer CAS 156223-05-1
Details :
Chemical name 3-[(3E)-3-[(2,4-dimethoxyphenyl)methylidene]-5,6-dihydro-4H-pyridin-2-yl]pyridine
Synonyms 3-(2,4-dimethoxy-benzylidene)anabaseine
Other name:DMBX-A
Cas: 156223-05-1
MF:C19H20N2O2
MW:308.374
Appearance: White powder
Purity:99%
GTS-21 (DMBX-A) is a derivative of the natural product anabaseine that acts as a partial agonist at neural nicotinic acetylcholine receptors. It binds to both the α4β2 and α7 subtypes, but activates only the α7 to any significant extent
Both GTS-21 itself and its demethylated active metabolite 4-OH-GTS-21 display nootropic and
neuroprotective effects, and GTS-21 is being investigated for the treatment ofAlzheimer's disease,
nicotine dependence,and, most significantly, for schizophrenia.
GTS-21 (DMXB-A) is being investigated for the treatment of Alzheimer's disease,nicotine dependence
99% 3-(2,4-dimethoxybenzylidene)anabaseine Manufacturer CAS 156223-05-1